NeoGenomics stock tumbles on weak EPS guidance By Investing.com NeoGenomics stock tumbles on weak EPS guidance…
NeoGenomics (NEO) Tops Q4 Earnings Estimates NeoGenomics (NEO) delivered earnings and revenue surprises of 100% and 0.92%, respectively, for the quarter ended December 2024. Do the…
NeoGenomics CEO steps down, shares fall 17% By Investing.com NeoGenomics CEO steps down, shares fall 17%…
Global Bioinformatics Services Market Size To Worth USD 12.71 Billion By 2033 | CAGR Of 14.40% The Global Bioinformatics Services Market Size was Valued at USD 3.31 Billion in 2023 and the Worldwide Bioinformatics Services Market…
Earnings call: NeoGenomics sees 14% revenue growth in Q1 2024 By Investing.com Earnings call: NeoGenomics sees 14% revenue growth in Q1 2024…
Does NeoGenomics (NEO) Have the Potential to Rally 43.34% as Wall Street Analysts Expect? The consensus price target hints at a 43.3% upside potential for NeoGenomics (NEO). While empirical research shows that this sought-after…